Filter
1224
Filtered Results: 1224
Text search:
in
vitro
Featured
Recommendations
145
New Publications
216
Language
Document type
No document type
477
Guidelines
356
Studies & Reports
194
Manuals
88
Fact sheets
51
Strategic & Response Plan
34
Training Material
12
Situation Updates
6
Resource Platforms
4
Brochures
1
Infographics
1
Countries / Regions
Latin America and the Carribbean
41
Brazil
41
Russia
36
India
31
Global
30
Colombia
25
Germany
25
South Africa
21
Paraguay
20
Argentina
17
Western and Central Europe
15
Mozambique
14
Africa
14
Venezuela
14
Sierra Leone
13
Bolivia
12
Angola
12
Peru
11
Ethiopia
10
Kenya
9
Middle East and North Africa
9
Ukraine
8
Rwanda
8
Cameroon
8
Burkina Faso
8
Eastern Europe
8
Zambia
8
Myanmar / Burma
8
Philippines
7
Tanzania
7
Spain
7
Uganda
7
Indonesia
7
Liberia
7
El Salvador
6
Syria
6
Nigeria
6
Eastern Europe and Central Asia
6
Namibia
6
Yemen
6
Chile
5
Guinea
5
West and Central Africa
5
South–East Asia Region
5
Ecuador
5
Senegal
4
Malawi
4
Italy
4
Haiti
4
Guinea-Bissau
4
France
4
Bangladesh
4
Nepal
3
Lesotho
3
Benin
3
Congo-Brazzaville
3
Niger
3
Congo, Democratic Republic of
3
East and Southern Africa
3
Mali
3
Eswatini/ Swaziland
3
Tajikistan
2
Ghana
2
Kazakhstan
2
Asia
2
Côte d’Ivoire / Ivory Coast
2
Vietnam
2
Sudan
2
Honduras
2
Chad
2
South Sudan
2
Madagascar
2
Guatemala
2
North Macedonia
1
Thailand
1
Mexico
1
Serbia
1
Turkey
1
Gambia
1
Togo
1
Albania
1
Canada
1
Laos
1
Kyrgyzstan
1
Uzbekistan
1
Afghanistan
1
Burundi
1
Zimbabwe
1
Morocco
1
Mongolia
1
Qatar
1
Mauritania
1
Armenia
1
USA
1
Dominican Republic
1
Jordan
1
Saudi Arabia
1
Luxembourg
1
North America
1
Belgium
1
Tunisia
1
Portugal
1
Belarus
1
Israel
1
Lebanon
1
Papua New Guinea
1
Nicaragua
1
Djibouti
1
Egypt
1
Palestine
1
Georgia
1
Libya
1
Iraq
1
Somalia
1
Cuba
1
Authors & Publishers
Publication Years
Category
Countries
403
Clinical Guidelines
179
Pharmacy & Technologies
55
Public Health
36
Women & Child Health
36
Key Resources
27
Capacity Building
3
Toolboxes
COVID-19
271
TB
129
HIV
115
NTDs
83
AMR
58
Ebola & Marburg
47
Rapid Response
43
Pharmacy
37
Zika
31
Planetary Health
27
Mental Health
19
Caregiver
19
Refugee
18
Global Health Education
12
Health Financing Toolbox
6
NCDs
6
Conflict
6
Polio
6
Specific Hazards
5
Natural Hazards
4
Cholera
4
Disability
3
Malaria
3
Social Ethics
1
The purpose of this document is to provide relevant information and guidelines on
coronavirus outbreaks – and in particular the novel coronavirus SARS-CoV-2 and the
diseases it produces, COVID-19 – for pharmacists and the pharmacy workforce, both in a
primary care context (i.e. community phar...
23 February 2021
This document describes the medical devices required for the clinical management of COVID-19, selected and prioritized according to the latest available evidence and interim guidelines. This includes: oxygen therapy, pulse oximeters, patient monitors, thermometers, infusion and suc...
Polio vaccines: WHO position paper – June 2022
recommended
This position paper on polio vaccines replaces the 2016 WHO position paper, and summarizes recent developments in the field.
The document "Priority medical devices list for the COVID-19 response and associated technical specifications" complements this guideline.
This document provides interim guidance on the quality, performance characteristics and related standards of personal protective equipment (PPE) to be used i...
The Guidance on global monitoring for diabetes prevention and control by WHO provides a comprehensive framework to support countries in tracking and managing diabetes prevention, care, and outcomes. This document outlines indicators across 4 domains: health system determinants, service delivery, ris...
There is no secret to our procedure: the daily scanning of the literature helps us to stay afloat in the never-ending waves of new publications about SARS-CoV-2 and COVID-19. Many papers discussed in the Top 10 will eventually make it into subsequent editions of COVID Reference.
Human African trypanosomiasis (HAT), or sleeping sickness, is an endemic disease in 36 sub-Saharan African countries, typically occurring in underdeveloped areas, where
health systems face significant difficulties of diverse natures.
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these...
This pocket guide offers basic information needed for the medical management of victims of radiation incidents in an easy-to-understand manner.
The key actions, activities, and approaches in this document are organized within each of the 5Cs (see Table 1 in the PDF) and those of the Strategic preparedness and response plan (SPRP) pillars as follows:
National action plan key activities, prioritized for the current context and the current ...
Interium guidance, 25 June 2021Timely and accurate diagnostic testing is an essential tool in preventing and controlling the spread of COVID-19. This document describes recommendations for national testing strategies and the use of PCR and rapid antigen tests in different transmission scenarios of t...
Module 10
Testing providers
July 2017
Module 10: Testing providers. This module is for people who provide testing services at PrEP sites and laboratories. It offers guidance in selecting testing services, including screening of individuals before PrEP is initiated and monitoring while they ar...
The Interim Guidance on Cholera Rapid Diagnostic Tests (RDTs) by the Global Task Force on Cholera Control (GTFCC) provides recommendations for using RDTs to detect cholera in areas with limited laboratory capacity. It highlights the advantages of RDTs, such as rapid detection (within 30 minutes), ea...
Meeting Report 27-29 October 2020
The overall goal of the meeting was to discuss recent changes in treatment regimens and diagnostics for drug-resistant TB and to determine how these impact on the definition of XDR-TB, with a view to revising this definition. The pre-existing definition of XDR-TB w...
July 2018
This fourth edition of the Unitaid/WHO market and technology landscape: HIV rapid diagnostic tests for self-testing report summarizes the current HIV testing gap; the challenges facing efforts to scale up; and the potential role HIV self-testing (HIVST) could play to achieve the United...
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
A large meta-analysis of observational studies that provided the basis for the recent makeover of global recommendations for multidrug-resistant tuberculosis (MDR-TB) treatment shows that newer and repurposed drugs produced better outcomes and fewer deaths than older treatments.
The meta-analysis...
The Zambia Population Based HIV impact assessment of 2016, reported the prevalence of viral hepatitis in Zambia as ranging between 5.6% among adults aged 15 to 59% in the general population, and 7.1% among HIV infected individuals. It is estimated that the majority of persons with chronic hepatitis ...
The growing understanding of how sequence information can contribute to improved public health is driving global investments in sequencing facilities and programmes. The falling cost and complexity of generating GSD provides opportunities for expanding sequencing capacity; however, challenges to wid...
These consolidated guidelines on HIV testing services (HTS) bring together existing and new guidance on HTS across different settings and populations.
The World Health Organization (WHO) first released consolidated guidelines on HTS in 2015, in response to requests from Member States, national pr...
